Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA PMA

implanted diaphragmatic/phrenic nerve Stimulator

PMA Number: P860026 · 2019-11-04

ApplicantAvery Biomedical Devices, Inc.
Decision Date2019-11-04
PMA NumberP860026
Product CodeGZE
Device ClassClass 3
Medical SpecialtyN
Regulation Number21 CFR 8
Advisory CommitteeAN

Device Summary

implanted diaphragmatic/phrenic nerve Stimulator is the device name listed in this FDA 510(k) record. The listed applicant is Avery Biomedical Devices, Inc.. It received FDA 510(k) clearance on 2019-11-04. The device is classified under product code GZE. It was reviewed by the AN advisory panel.

Frequently Asked Questions

What is the implanted diaphragmatic/phrenic nerve Stimulator?

implanted diaphragmatic/phrenic nerve Stimulator is a medical device that received FDA 510(k) clearance on 2019-11-04. The listed applicant is Avery Biomedical Devices, Inc..

When did implanted diaphragmatic/phrenic nerve Stimulator receive FDA 510(k) clearance?

The clearance date for implanted diaphragmatic/phrenic nerve Stimulator can be found in the official FDA records.

Who is the listed applicant for implanted diaphragmatic/phrenic nerve Stimulator?

The FDA 510(k) record lists Avery Biomedical Devices, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for implanted diaphragmatic/phrenic nerve Stimulator?

The FDA product code for implanted diaphragmatic/phrenic nerve Stimulator is GZE.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT04745156A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade GliomasNOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑